|
US3138588A
(en)
|
1962-08-24 |
1964-06-23 |
American Home Prod |
17-ketals of estrone and derivatives thereof
|
|
US3433785A
(en)
|
1966-07-11 |
1969-03-18 |
Sterling Drug Inc |
15,16-disubstituted aromatic steroids,intermediates and processes
|
|
US4826831A
(en)
|
1983-08-05 |
1989-05-02 |
Pre Jay Holdings Limited |
Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
|
|
CA1306950C
(en)
|
1987-04-10 |
1992-09-01 |
Alec D. Keith |
Buccal administration of estrogens
|
|
US5073374A
(en)
*
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
|
GB2228412B
(en)
|
1989-02-28 |
1993-04-14 |
Syntex Inc |
Nicardipine pharmaceutical composition for parenteral administration
|
|
US5340585A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Method and formulations for use in treating benign gynecological disorders
|
|
US5340586A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Methods and formulations for use in treating oophorectomized women
|
|
US5895783A
(en)
|
1993-07-16 |
1999-04-20 |
Schering Aktiengesellschaft |
Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
|
|
JPH07101977A
(ja)
|
1993-10-05 |
1995-04-18 |
Kureha Chem Ind Co Ltd |
ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
|
|
DE4344405C2
(de)
|
1993-12-24 |
1995-12-07 |
Marika Dr Med Ehrlich |
Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
|
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
|
FR2772272B1
(fr)
|
1997-12-16 |
2000-01-14 |
Rhone Poulenc Rorer Sa |
Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
|
|
CA2315088A1
(en)
|
1997-12-19 |
1999-07-01 |
Smithkline Beecham Corporation |
Process for manufacturing bite-dispersion tablets
|
|
US7815937B2
(en)
|
1998-10-27 |
2010-10-19 |
Biovail Laboratories International Srl |
Quick dissolve compositions and tablets based thereon
|
|
US6117446A
(en)
|
1999-01-26 |
2000-09-12 |
Place; Virgil A. |
Drug dosage unit for buccal administration of steroidal active agents
|
|
US6180682B1
(en)
*
|
1999-01-26 |
2001-01-30 |
Virgil A. Place |
Buccal drug delivery system for use in male contraception
|
|
TW548277B
(en)
|
1999-07-16 |
2003-08-21 |
Akzo Nobel Nv |
Orally active androgens
|
|
AU778017B2
(en)
|
1999-12-02 |
2004-11-11 |
N.V. Organon |
14,15-beta-methylene substituted androgens
|
|
US20020132801A1
(en)
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
|
FR2809619B1
(fr)
|
2000-06-06 |
2004-09-24 |
Pharmatop |
Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
|
|
EP1216713A1
(en)
|
2000-12-20 |
2002-06-26 |
Schering Aktiengesellschaft |
Compositions of estrogen-cyclodextrin complexes
|
|
DK1390040T3
(da)
|
2001-05-18 |
2007-04-23 |
Pantarhei Bioscience Bv |
Farmaceutisk præparat til anvendelse i hormonerstatningsterapi
|
|
EP1260225A1
(en)
|
2001-05-18 |
2002-11-27 |
Pantarhei Bioscience B.V. |
A pharmaceutical composition for use in hormone replacement therapy
|
|
US7871995B2
(en)
|
2001-05-23 |
2011-01-18 |
Pantarhei Bioscience B.V. |
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
|
|
ES2208518T3
(es)
*
|
2001-05-23 |
2004-06-16 |
Pantarhei Bioscience B.V. |
Medio y metodo anticonceptivo hormonal.
|
|
EP1390042B1
(en)
|
2001-05-23 |
2007-11-28 |
Pantarhei Bioscience B.V. |
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
|
|
US20020193356A1
(en)
|
2001-05-23 |
2002-12-19 |
Van Beek Agatha Antonia Magdalena |
Means and method for hormonal contraception
|
|
WO2003018026A1
(en)
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
DE60216630T2
(de)
|
2001-11-15 |
2007-09-20 |
Pantarhei Bioscience B.V. |
Verwendung von östrogen in kombination mit progestogen für die hormonsubstitutiionstherapie
|
|
US6723348B2
(en)
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
|
HU227198B1
(en)
|
2001-11-27 |
2010-10-28 |
Richter Gedeon Nyrt |
Pharmaceutical composition for emergency contraception containing levonorgestrel
|
|
BR0215613A
(pt)
|
2002-02-21 |
2004-12-07 |
Schering Ag |
Composições farmacêuticas que compreendem um ou mais esteróides, um ou mais componentes tetrahidrofolato e vitamina b12
|
|
US20050147670A1
(en)
|
2002-05-29 |
2005-07-07 |
Impax Laboratories Inc. |
Oral disintegrating dosage forms
|
|
CA2489271C
(en)
|
2002-06-11 |
2011-12-06 |
Pantarhei Bioscience B.V. |
Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
|
|
AU2003274941A1
(en)
|
2002-06-11 |
2003-12-22 |
Pantarhei Bioscience B.V. |
A method of treating human skin and a skin care composition for use in such a method
|
|
US9034854B2
(en)
|
2002-07-12 |
2015-05-19 |
Pantarhei Bioscience B.V. |
Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
|
|
CN1678324A
(zh)
|
2002-08-28 |
2005-10-05 |
罗伯特·卡斯珀 |
雌激素替代治疗方案
|
|
AU2003274823A1
(en)
|
2002-10-23 |
2004-05-13 |
Pantarhei Bioscience B.V. |
Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
|
|
WO2004041289A1
(en)
|
2002-11-05 |
2004-05-21 |
Schering Aktiengesellschaft |
Cardiovascular protection using anti-aldosteronic progestins
|
|
DK1562976T3
(da)
|
2002-11-08 |
2010-08-16 |
Pantarhei Bioscience Bv |
Syntese af estetrol via estron-afledte steroider
|
|
DK1624878T3
(da)
|
2003-05-22 |
2007-01-08 |
Pantarhei Bioscience Bv |
Anvendelse af præparater som omfatter en östrogen komponent til behandling og forebyggelse af muskel-skelet-smerte
|
|
WO2005030175A1
(en)
|
2003-09-29 |
2005-04-07 |
Novo Nordisk Femcare Ag |
Hrt formulations
|
|
ES2933479T3
(es)
|
2003-09-29 |
2023-02-09 |
Novo Nordisk Healthcare Ag |
Estabilidad mejorada de formulaciones de progestágenos
|
|
JP3841804B2
(ja)
|
2003-10-15 |
2006-11-08 |
富士化学工業株式会社 |
口腔内速崩壊性錠剤用の組成物
|
|
EP1535618A1
(en)
|
2003-11-26 |
2005-06-01 |
Schering Aktiengesellschaft |
Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
|
|
MY151322A
(en)
|
2004-04-30 |
2014-05-15 |
Bayer Ip Gmbh |
Management of breakthrough bleeding in extended hormonal contraceptive regimens
|
|
GB0410616D0
(en)
|
2004-05-13 |
2004-06-16 |
Unilever Plc |
Antiperspirant or deodorant compositions
|
|
SI1755562T1
(sl)
|
2004-05-28 |
2014-02-28 |
Richter Gedeon Nyrt. |
Kontracepcijsko sredstvo, ki vsebuje folno kislino
|
|
DE102004026670A1
(de)
|
2004-05-28 |
2005-12-15 |
Grünenthal GmbH |
Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
|
|
DE602005013232D1
(de)
|
2004-07-01 |
2009-04-23 |
Lek Pharmaceuticals |
Schnell zerfallende im mund dispergierbare zusammensetzung mit nicht-filamentösen mitverarbeiteten polyol-teilchen und verkieselter mikrokristalliner cellulose
|
|
UA89964C2
(ru)
|
2004-09-08 |
2010-03-25 |
Н.В. Органон |
15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
|
|
AU2006211023B2
(en)
|
2005-02-03 |
2012-05-24 |
Takeda Nycomed As |
Fast wet-massing method for the preparation of calcium-containing compositions
|
|
IS7724A
(is)
|
2005-03-02 |
2006-09-03 |
Actavis Group |
Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
|
|
UY29527A1
(es)
|
2005-05-13 |
2006-12-29 |
Schering Ag |
Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
|
|
MX2007014736A
(es)
|
2005-05-26 |
2008-02-15 |
Solvay Pharm Gmbh |
17beta-hsd1 e inhibidores sts.
|
|
US20070048369A1
(en)
*
|
2005-08-26 |
2007-03-01 |
National Starch And Chemical Investment Holding Corporation |
Mucosal delivery tablet
|
|
ES2352547T3
(es)
*
|
2006-01-09 |
2011-02-21 |
Pantarhei Bioscience B.V. |
Método para tratar un trastorno vascular agudo.
|
|
EP1971344B1
(en)
|
2006-01-09 |
2010-09-22 |
Pantarhei Bioscience B.V. |
A method of treating an acute vascular disorder
|
|
CA2640520C
(en)
|
2006-03-02 |
2014-04-22 |
Warner Chilcott Company, Inc. |
Extended cycle multiphasic oral contraceptive method
|
|
MX2008014941A
(es)
*
|
2006-06-08 |
2008-12-10 |
Warner Chilcott Co Inc |
Metodos para administrar formas de dosificacion solida de etinil estradiol y profarmacos del mismo con biodisponibilidad mejorada.
|
|
US20070286819A1
(en)
*
|
2006-06-08 |
2007-12-13 |
Warner Chilcott Company, Inc. |
Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
US20080113953A1
(en)
|
2006-06-08 |
2008-05-15 |
Warner Chilcott Company, Inc. |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
CN101489563A
(zh)
|
2006-07-06 |
2009-07-22 |
拜耳先灵医药股份有限公司 |
用于避孕和预防先天性畸形风险的药物制剂
|
|
KR20090029824A
(ko)
|
2006-07-06 |
2009-03-23 |
바이엘 쉐링 파마 악티엔게젤샤프트 |
피임용 및 선천성 기형 위험 예방용 제약 제제
|
|
AU2007325207A1
(en)
|
2006-11-29 |
2008-06-05 |
Wyeth |
Estrogen/ serm and estrogen/ progestin bi-layer tablets
|
|
AU2007338843B2
(en)
|
2006-12-20 |
2013-05-09 |
Teva Women's Health, Inc. |
Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
|
|
CN101583363B
(zh)
|
2007-01-08 |
2013-08-21 |
潘塔希生物科学股份有限公司 |
治疗或预防雌性哺乳动物不育症的方法和此类方法中使用的药物试剂盒
|
|
CL2008000095A1
(es)
|
2007-01-12 |
2008-05-16 |
Wyeth Corp |
Composicion de tableta en tableta que comprende una tableta central con estrogenos, un rellenador/diluyente, un rellenador/aglomerante, un componente polimerico y una capa de tableta exterior comprimida con agentes terapeuticos, un rellenador/diluyen
|
|
EP1972618A1
(en)
|
2007-03-20 |
2008-09-24 |
Nabriva Therapeutics AG |
Pleuromutilin derivatives for the treatment of diseases mediated by microbes
|
|
ATE537833T1
(de)
|
2007-06-21 |
2012-01-15 |
Pantarhei Bioscience Bv |
Behandlung des mekoniumaspirationssyndroms mit östrogenen
|
|
US8518923B2
(en)
|
2007-07-19 |
2013-08-27 |
Pantarhei Bioscience B.V. |
Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation
|
|
FR2920311B1
(fr)
|
2007-08-31 |
2010-06-18 |
Galenix Innovations |
Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
|
|
JP5399749B2
(ja)
|
2008-03-27 |
2014-01-29 |
沢井製薬株式会社 |
プロトンポンプ阻害剤を含有する被覆微粒子
|
|
WO2010033832A2
(en)
|
2008-09-19 |
2010-03-25 |
Evestra, Inc. |
Estriol formulations
|
|
CN101780073B
(zh)
|
2009-01-21 |
2013-07-03 |
重庆圣华曦药业股份有限公司 |
非布司他分散片药物及其制备方法
|
|
EP3031451B1
(en)
|
2009-01-26 |
2018-03-07 |
Shin-Etsu Chemical Co., Ltd |
Wet granulation tableting method using aqueous dispersion of low-substituted hydroxypropyl cellulose
|
|
DE102009007771B4
(de)
|
2009-02-05 |
2012-02-16 |
Bayer Schering Pharma Aktiengesellschaft |
Bukkales Applikationssystem, 17α-Estradiol enthaltend
|
|
JP2012521393A
(ja)
|
2009-03-26 |
2012-09-13 |
ロイヤル カレッジ オブ サージェオンズ イン アイルランド |
口腔内分散性錠剤
|
|
CN102458386B
(zh)
|
2009-06-23 |
2016-04-06 |
拜耳知识产权有限责任公司 |
用于紧急避孕的药物组合物
|
|
ITMI20091109A1
(it)
|
2009-06-23 |
2010-12-24 |
Wyeth Corp |
Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione
|
|
CN102058604A
(zh)
|
2009-11-17 |
2011-05-18 |
北京万全阳光医学技术有限公司 |
一种含有地诺孕素和戊酸雌二醇的药物组合物及其制备方法
|
|
US20130137664A1
(en)
|
2010-04-15 |
2013-05-30 |
Bayer Intellectual Property Gmbh |
Low-dosed solid oral dosage forms for hrt
|
|
EP2399904A1
(en)
|
2010-05-26 |
2011-12-28 |
Nabriva Therapeutics AG |
Process for the preparation of pleuromutilins
|
|
US10849857B2
(en)
|
2010-07-28 |
2020-12-01 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
|
AR081670A1
(es)
|
2010-06-29 |
2012-10-10 |
Leon Farma Sa Lab |
Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
|
|
US9603860B2
(en)
|
2010-07-28 |
2017-03-28 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
|
WO2012055840A1
(en)
|
2010-10-28 |
2012-05-03 |
Bayer Pharma Aktiengesellschaft |
Composition and preparation for treatment of dysmenorrhea and menstrual pain and use of a hormonal agent and a zinc salt for treatment of menstrual disorders
|
|
CA2819663C
(en)
|
2010-12-02 |
2019-12-24 |
Adare Pharmaceuticals, Inc. |
Rapidly dispersing granules, orally disintegrating tablets and methods
|
|
JP2012240917A
(ja)
|
2011-05-16 |
2012-12-10 |
Zensei Yakuhin Kogyo Kk |
製剤化用微粒子とそれを含む製剤
|
|
SG195121A1
(en)
|
2011-06-01 |
2013-12-30 |
Estetra S A |
Process for the production of estetrol intermediates
|
|
HUE029252T2
(en)
|
2011-06-01 |
2017-02-28 |
Estetra Sprl |
Process for the preparation of intermediates of estetrol
|
|
EP2383279A1
(en)
|
2011-07-19 |
2011-11-02 |
Pantarhei Bioscience B.V. |
Process for the preparation of estetrol
|
|
ES2545337T3
(es)
|
2011-07-19 |
2015-09-10 |
Pantarhei Bioscience B.V. |
Comprimido que contiene dehidroepiandrosterona (DHEA)
|
|
HRP20170797T1
(hr)
|
2011-08-11 |
2017-08-11 |
Estetra S.P.R.L. |
Primjena estetrola kao hitnog kontraceptiva
|
|
CN103781467B
(zh)
|
2011-09-16 |
2016-08-31 |
辉凌公司 |
一种快速溶解药物组合物
|
|
EP2764008B1
(en)
|
2011-10-07 |
2016-08-17 |
Estetra S.P.R.L. |
Process for the production of estetrol
|
|
WO2013090117A1
(en)
|
2011-12-13 |
2013-06-20 |
Arstat, Inc. |
A multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen
|
|
US9808470B2
(en)
|
2012-04-19 |
2017-11-07 |
Universite De Liege |
Estrogenic components for use in the treatment of neurological disorders
|
|
EP2653163A1
(en)
|
2012-04-19 |
2013-10-23 |
Université de Liège |
Estrogenic components for use in the treatment of neurological disorders
|
|
US9238265B2
(en)
|
2012-09-27 |
2016-01-19 |
General Electric Company |
Backstrike protection during machining of cooling features
|
|
WO2014159377A1
(en)
*
|
2013-03-14 |
2014-10-02 |
Teva Women's Health, Inc. |
Compositions containing tanaproget and natural estrogens
|
|
JP6126456B2
(ja)
|
2013-05-17 |
2017-05-10 |
東和薬品株式会社 |
打錠用顆粒とその製造方法、その打錠用顆粒を用いた口腔内崩壊錠
|
|
KR20160013098A
(ko)
|
2013-05-21 |
2016-02-03 |
프리딕티브 테라퓨틱스, 엘엘씨 |
치료제 및 그 사용 방법
|
|
EP3046928B1
(en)
|
2013-09-18 |
2017-02-08 |
Crystal Pharma, S.A.U. |
Process for the preparation of estetrol
|
|
US12274276B2
(en)
|
2013-10-03 |
2025-04-15 |
Altria Client Services Llc |
Dissolvable-chewable tablet
|
|
NO3079671T3
(https=)
|
2013-12-12 |
2018-03-24 |
|
|
|
ES2957543T3
(es)
|
2014-09-29 |
2024-01-22 |
Univ California |
Composiciones y métodos para mantener la función cognitiva
|
|
WO2016187269A1
(en)
|
2015-05-18 |
2016-11-24 |
Agile Therapeutics, Inc. |
Contraceptive compositions and methods for improved efficacy and modulation of side effects
|
|
MD3310333T2
(ro)
|
2015-06-18 |
2020-06-30 |
Estetra Sprl |
Unitate de dozare orodispersabilă care conține un component estetrol
|
|
CN116077454A
(zh)
|
2015-06-18 |
2023-05-09 |
埃斯特拉有限责任公司 |
含雌四醇组分的口腔分散剂量单位
|
|
HUE054589T2
(hu)
|
2015-06-18 |
2021-09-28 |
Estetra Sprl |
Szájban diszpergálódó esztetrol tartalmú tabletta
|
|
RS61777B1
(sr)
|
2015-06-18 |
2021-06-30 |
Estetra Sprl |
Oralno-disperzibilna tableta koja sadrži estetrol
|
|
CA2989975C
(en)
|
2015-06-23 |
2021-10-12 |
Laboratorios Leon Farma Sa |
Drospirenone-based contraceptive for a female patient affected with excess weight
|
|
KR102780201B1
(ko)
|
2016-10-28 |
2025-03-12 |
에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 |
월경통 및 생리통의 관리방법
|
|
CA3178291A1
(en)
|
2016-08-05 |
2018-04-12 |
Estetra Srl |
Method for the management of dysmenorrhea and menstrual pain
|
|
US20200046729A1
(en)
|
2016-08-05 |
2020-02-13 |
Estetra Sprl |
Methods using combined oral contraceptive compositions with reduced cardiovascular effects
|
|
CN111683664A
(zh)
|
2018-02-07 |
2020-09-18 |
埃斯特拉私人有限责任公司 |
具有降低的心血管作用的避孕组合物
|
|
TWI801561B
(zh)
|
2018-04-19 |
2023-05-11 |
比利時商依思特拉私人有限責任公司 |
化合物及其用於緩解絕經相關症狀的用途
|
|
DK3781171T3
(da)
|
2018-04-19 |
2022-05-02 |
Estetra Srl |
Sammensætninger og deres anvendelser til lindring af menopause-associerede symptomer
|
|
TWI893101B
(zh)
|
2020-04-16 |
2025-08-11 |
比利時商埃斯特拉有限責任公司 |
具有降低之副作用之避孕組成物
|